Integrative Molecular and Phytotherapeutic Strategies in Alzheimer’s Disease: A Review of Advances in Pathogenesis, Genetic Markers, And Natural Drug Design

Abstract

Alzheimer’s Disease (AD) is a complex brain disorder involving memory loss and cognitive decline. This review highlights recent progress in understanding how certain genes and brain pathways contribute to the disease. It also explores the role of plant-based compounds, such as curcumin and silymarin, in reducing brain inflammation and protein buildup. Advances in computer-based drug design and personalized medicine are discussed, along with the ongoing challenges in developing treatments that are both effective and easy for the brain to absorb. A combined approach using genetics, natural therapies, and technology may offer better solutions for managing AD.